Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells

Junlan Zhou, Min Cheng, Yu Hua Liao, Yu Hu, Min Wu, Qing Wang, Bo Qin, Hong Wang, Yan Zhu, Xiu Mei Gao, David Goukassian, Ting C. Zhao, Yao Liang Tang, Raj Kishore, Gangjian Qin

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Circulating endothelial progenitor cells (circEPCs) of bone marrow (BM) origin contribute to postnatal neovascularization and represent a potential therapeutic target for ischemic disease. Statins are beneficial for ischemia disease and have been implicated to increase neovascularization via mechanisms independent of lipid lowering. However, the effect of Statins on EPC function is not completely understood. Here we sought to investigate the effects of Rosuvastatin (Ros) on EPC mobilization and EPC-mediated neovascularization during ischemic injury. In a mouse model of surgically-induced hindlimb ischemia (HLI), treatment of mice with low dose (0.1 mg/kg) but not high dose (5 mg/kg) significantly increased capillary density and accelerated blood flow recovery, as compared to saline-treated group. When HLI was induced in mice that had received Tie2/LacZ BM transplantation, Ros treatment led a significantly larger amount of endothelial cells (ECs) of BM origin incorporated at ischemic sites than saline. After treatment of mice with a single low dose of Ros, circEPCs significantly increased from 2 h, peaked at 4 h, declined until 8 h. In a growth-factor reduced Matrigel plug-in assay, Ros treatment for 5 d induced endothelial lineage differentiation in vivo. Interestingly, the enhanced circEPCs and post-HLI neovascularization stimulated by Ros were blunted in mice deficient in endothelial nitric oxide synthase (eNOS), and Ros increased p-Akt/p-eNOS levels in EPCs in vitro, indicating these effects of Ros are dependent on eNOS activity. We conclude that Ros increases circEPCs and promotes their de novo differentiation through eNOS pathway.

Original languageEnglish (US)
Article numbere63126
JournalPloS one
Volume8
Issue number5
DOIs
StatePublished - May 21 2013
Externally publishedYes

Fingerprint

Nitric Oxide Synthase Type III
Endothelial cells
angiogenesis
endothelial cells
stem cells
ischemia
mice
Hindlimb
Ischemia
bone marrow
Hydroxymethylglutaryl-CoA Reductase Inhibitors
dosage
Bone
bone marrow transplant
Bone Marrow
blood flow
growth factors
Therapeutics
animal models
endothelial nitric oxide synthase

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Zhou, J., Cheng, M., Liao, Y. H., Hu, Y., Wu, M., Wang, Q., ... Qin, G. (2013). Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells. PloS one, 8(5), [e63126]. https://doi.org/10.1371/journal.pone.0063126

Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells. / Zhou, Junlan; Cheng, Min; Liao, Yu Hua; Hu, Yu; Wu, Min; Wang, Qing; Qin, Bo; Wang, Hong; Zhu, Yan; Gao, Xiu Mei; Goukassian, David; Zhao, Ting C.; Tang, Yao Liang; Kishore, Raj; Qin, Gangjian.

In: PloS one, Vol. 8, No. 5, e63126, 21.05.2013.

Research output: Contribution to journalArticle

Zhou, J, Cheng, M, Liao, YH, Hu, Y, Wu, M, Wang, Q, Qin, B, Wang, H, Zhu, Y, Gao, XM, Goukassian, D, Zhao, TC, Tang, YL, Kishore, R & Qin, G 2013, 'Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells', PloS one, vol. 8, no. 5, e63126. https://doi.org/10.1371/journal.pone.0063126
Zhou, Junlan ; Cheng, Min ; Liao, Yu Hua ; Hu, Yu ; Wu, Min ; Wang, Qing ; Qin, Bo ; Wang, Hong ; Zhu, Yan ; Gao, Xiu Mei ; Goukassian, David ; Zhao, Ting C. ; Tang, Yao Liang ; Kishore, Raj ; Qin, Gangjian. / Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells. In: PloS one. 2013 ; Vol. 8, No. 5.
@article{25050af05ad0443dae5ed572b066b196,
title = "Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells",
abstract = "Circulating endothelial progenitor cells (circEPCs) of bone marrow (BM) origin contribute to postnatal neovascularization and represent a potential therapeutic target for ischemic disease. Statins are beneficial for ischemia disease and have been implicated to increase neovascularization via mechanisms independent of lipid lowering. However, the effect of Statins on EPC function is not completely understood. Here we sought to investigate the effects of Rosuvastatin (Ros) on EPC mobilization and EPC-mediated neovascularization during ischemic injury. In a mouse model of surgically-induced hindlimb ischemia (HLI), treatment of mice with low dose (0.1 mg/kg) but not high dose (5 mg/kg) significantly increased capillary density and accelerated blood flow recovery, as compared to saline-treated group. When HLI was induced in mice that had received Tie2/LacZ BM transplantation, Ros treatment led a significantly larger amount of endothelial cells (ECs) of BM origin incorporated at ischemic sites than saline. After treatment of mice with a single low dose of Ros, circEPCs significantly increased from 2 h, peaked at 4 h, declined until 8 h. In a growth-factor reduced Matrigel plug-in assay, Ros treatment for 5 d induced endothelial lineage differentiation in vivo. Interestingly, the enhanced circEPCs and post-HLI neovascularization stimulated by Ros were blunted in mice deficient in endothelial nitric oxide synthase (eNOS), and Ros increased p-Akt/p-eNOS levels in EPCs in vitro, indicating these effects of Ros are dependent on eNOS activity. We conclude that Ros increases circEPCs and promotes their de novo differentiation through eNOS pathway.",
author = "Junlan Zhou and Min Cheng and Liao, {Yu Hua} and Yu Hu and Min Wu and Qing Wang and Bo Qin and Hong Wang and Yan Zhu and Gao, {Xiu Mei} and David Goukassian and Zhao, {Ting C.} and Tang, {Yao Liang} and Raj Kishore and Gangjian Qin",
year = "2013",
month = "5",
day = "21",
doi = "10.1371/journal.pone.0063126",
language = "English (US)",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells

AU - Zhou, Junlan

AU - Cheng, Min

AU - Liao, Yu Hua

AU - Hu, Yu

AU - Wu, Min

AU - Wang, Qing

AU - Qin, Bo

AU - Wang, Hong

AU - Zhu, Yan

AU - Gao, Xiu Mei

AU - Goukassian, David

AU - Zhao, Ting C.

AU - Tang, Yao Liang

AU - Kishore, Raj

AU - Qin, Gangjian

PY - 2013/5/21

Y1 - 2013/5/21

N2 - Circulating endothelial progenitor cells (circEPCs) of bone marrow (BM) origin contribute to postnatal neovascularization and represent a potential therapeutic target for ischemic disease. Statins are beneficial for ischemia disease and have been implicated to increase neovascularization via mechanisms independent of lipid lowering. However, the effect of Statins on EPC function is not completely understood. Here we sought to investigate the effects of Rosuvastatin (Ros) on EPC mobilization and EPC-mediated neovascularization during ischemic injury. In a mouse model of surgically-induced hindlimb ischemia (HLI), treatment of mice with low dose (0.1 mg/kg) but not high dose (5 mg/kg) significantly increased capillary density and accelerated blood flow recovery, as compared to saline-treated group. When HLI was induced in mice that had received Tie2/LacZ BM transplantation, Ros treatment led a significantly larger amount of endothelial cells (ECs) of BM origin incorporated at ischemic sites than saline. After treatment of mice with a single low dose of Ros, circEPCs significantly increased from 2 h, peaked at 4 h, declined until 8 h. In a growth-factor reduced Matrigel plug-in assay, Ros treatment for 5 d induced endothelial lineage differentiation in vivo. Interestingly, the enhanced circEPCs and post-HLI neovascularization stimulated by Ros were blunted in mice deficient in endothelial nitric oxide synthase (eNOS), and Ros increased p-Akt/p-eNOS levels in EPCs in vitro, indicating these effects of Ros are dependent on eNOS activity. We conclude that Ros increases circEPCs and promotes their de novo differentiation through eNOS pathway.

AB - Circulating endothelial progenitor cells (circEPCs) of bone marrow (BM) origin contribute to postnatal neovascularization and represent a potential therapeutic target for ischemic disease. Statins are beneficial for ischemia disease and have been implicated to increase neovascularization via mechanisms independent of lipid lowering. However, the effect of Statins on EPC function is not completely understood. Here we sought to investigate the effects of Rosuvastatin (Ros) on EPC mobilization and EPC-mediated neovascularization during ischemic injury. In a mouse model of surgically-induced hindlimb ischemia (HLI), treatment of mice with low dose (0.1 mg/kg) but not high dose (5 mg/kg) significantly increased capillary density and accelerated blood flow recovery, as compared to saline-treated group. When HLI was induced in mice that had received Tie2/LacZ BM transplantation, Ros treatment led a significantly larger amount of endothelial cells (ECs) of BM origin incorporated at ischemic sites than saline. After treatment of mice with a single low dose of Ros, circEPCs significantly increased from 2 h, peaked at 4 h, declined until 8 h. In a growth-factor reduced Matrigel plug-in assay, Ros treatment for 5 d induced endothelial lineage differentiation in vivo. Interestingly, the enhanced circEPCs and post-HLI neovascularization stimulated by Ros were blunted in mice deficient in endothelial nitric oxide synthase (eNOS), and Ros increased p-Akt/p-eNOS levels in EPCs in vitro, indicating these effects of Ros are dependent on eNOS activity. We conclude that Ros increases circEPCs and promotes their de novo differentiation through eNOS pathway.

UR - http://www.scopus.com/inward/record.url?scp=84877934261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877934261&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0063126

DO - 10.1371/journal.pone.0063126

M3 - Article

C2 - 23704894

AN - SCOPUS:84877934261

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 5

M1 - e63126

ER -